News Items
Am I Hypothyroid or Thyroid Hormone Resistant? Hypothyroid patients often ask me whether I think they are actually resistant to thyroid hormone rather than hypothyroid. They usually ask after undergoing treatment with a T4/T3 product, such as Armour, that hasn’t gotten them completely well. Of course, my answer is always conjectural. The reason is simple: for most patients who are resistant, we learn of their resistance only after they’ve gone through the proper treatment for thyroid hormone resistance. (In The Metabolic Treatment of Fibormyalgia, I described the treatment outcome that indicates thyroid hormone resistance: after treatment with fairly large doses of T3, the patient’s hypothyroid-like symptoms are gone, and, although their free T3 levels are extremely high, the patient has no symptoms of tissue overstimulation. [2,p.282]) But based on long clinical and research experience with both hypothyroid and resistant patients, I can often give an answer that I’m reasonably sure is true.My answer to patients often differs. One reason is that the factors differ that I must consider in formulating an opinion. So many patients ask this question, though, that I believe our readers may find it interesting to consider one case, and the factors that I had to consider to come to a conjecture for her. The patient in question had come to our clinic for a full metabolic evaluation. Every physiologic test gave abnormal results: Her resting metabolic rate was 42% below normal; her basal body temperature was 96.9 F (36.06 C); the voltage of her electrocardiogram was low; and the relaxation phase of her Achilles reflex was abnormally slow. She also had classic symptoms of hypothyroidism. These included chronic back pain, fatigue, stiffness, coldness, anxiety, and intolerance of exercise. And she hadn’t had a menstrual period for more than two years. (In 2005, an endocrinologist had diagnosed the cause of her amenorrhea as thyroiditis, but he didn’t prescribe treatment.) Laboratory test results were revealing: her cholesterol and LDL were high, and her thyroglobulin antibodies and especially her thyroid peroxidase antibodies were very high. Yet her TSH, free T3, and free T4 were "normal." I did a deductive differential diagnosis to eliminate the possibility that anything other than autoimmune-induced hypothyroidism was the cause of her abnormal test results and symptoms. This deductive process showed only one rational conclusion: she was suffering from severe hypothyroidism caused by active autoimmune thyroiditis. The year before, a doctor had treated her with 50 mcg of Synthroid. As any observant clinician with an open mind would anticipate, this treatment failed her. Before she consulted me, another doctor treated her with 90 mg of Armour Thyroid. Armour, of course, is vastly superior to Synthroid. Nonetheless, the 90 mg of Armour left her with low metabolism, other abnormal test results, and troubling hypothyroid symptoms. After I evaluated her condition, I pointed out something important in her report to her and her prescribing doctor: historically, most hypothyroid patients safely got well on products such as Armour with dosages between 120 and 240 mg. Pearch and Himsworth noted in the British Medical Journal that in the long history of patients using such dosages, they suffered no harmful effects from doing so. [1,p.695] In The Metabolic Treatment of Fibromyalgia,[2] I heavily documented the truth of Pearch and Himsworth’s notation, not only for hypothyroid patients, but also for patients with thyroid hormone resistance.Knowing that this dosage range is safe for the vast majority of patients, I advised the patient’s doctor to increase her dosage of Armour. The doctor cooperated. At 150 mg (2.5 grains), she had improved. Her basal temperature had increased from an average of 96.9 F (36.06 C) to 97.45 F (36.36 C). Also, at long last, last month she had a menstruated. Her thyroglobulin level decreased from 35 to 31, and her thyroid peroxidase antibodies decreased from 703 to 573. Her exercise intolerance still depressed her somewhat, but now she could also exercise some; for example, unlike before, she was exercising by walking, and she had lost 2 lbs. She denied any indication of thyroid hormone overstimulation. Then came the question I hear so often: "Do you think I’m resistant to thyroid hormone?" I got the impression that she asked the question because her doctor was concerned that her low TSH (0.03 mU/L) indicated that she was taking too much Armour. The implication, of course, would be that if she’s taking too much thyroid hormone and has improved so little, then maybe she’s thyroid hormone resistant. I did some quick calculations and then told her that I see no reason at this point to think she is resistant. She may turn out to have some degree of resistance, but for now, its clear only that she’s hypothyroid. I say this because her dosage is only a short distance into the dosage range that, before lab tests came to dominate doctors’ decisions, was known to be safe and effective for patients. With that dosage (150 mg), she has improved somewhat. Of course, to fully recover, she may have to proceed—as many patients traditionally did—to 175 mg, 200 mg, or even a higher dosage. I explained my reasoning to her: Most resistance patients don’t improve or recover with T4. They do so only with T3, and then only with fairly high doses. Her dosage of 150 mg of Armour contains 95 mcg of T4, but that’s really of no relevance to the question of whether she’s resistant. Few if any resistance patients improve with T4 therapy no matter how high their dosages. The 150 mg of Armour, however, contains 22.5 mcg of T3, and that is relevant to the question of resistance. If she is resistant, chances are that the T4 was not responsible for her improvements. At the same time, the 22.5 mcg of T3 she was taking was too little to give a resistance patient the improvements she’d gotten so far. Most patients have to take far more T3 to improve or recover. Had she not improved at all on the 150 mg of Armour, we would have some reason to reserve judgment about possible resistance. In that case, maybe she wouldn’t improve even if she reached the upper end of the dosage range, 240 mg, that traditionally has gotten hypothyroid patients safely well. In that case, it would be reasonable to consider that she’s resistant to thyroid hormone. It would probably be appropriate then for her doctor to switch her from Armour to plain T3 and allow her to go through the treatment regimen proper for resistance patients. [2]References 1. Pearch, C.J. and Himsworth, R.L.: Total and free thyroid hormone concentration in 2. Lowe, J.C.: The Metabolic Treatment of Fibromyalgia. Boulder, McDowell Publishing Co., 2000.
When I was nineteen-years old, in 1965, my older brother, Harvey, fortuitously prompted me to read several books by a clinical psychologist named Dr. Albert Ellis. Through his books, Dr. Ellis' bold beliefs and powerful personality gripped my mind and changed my course in life. I wasn't the only one thusly influenced by this extraordinary human being. Dr. Ellis died on July 24, 2007 at the age of 93. The year before, the American Psychological Association voted him the second most influential psychologist in history, out ranking Sigmund Freud. At nineteen, as a young man from lower blue-color stock, presumption and prejudice had largely shaped and still drove my mind. Being equipped only with these poor sources of mentality, encountering the steadfast, rigorous rationality of Dr. Ellis, courageously espoused by his mighty personality, was profoundly life-changing for me. Shortly into reading his books, I wanted to learn whatever I could about this extraordinary man. So I went to the Pensacola Public Library. There, a kind librarian directed me to Marquis Who's Who in America, the most authoritative source of biographical information on accomplished Americans. There, I learned enough to satisfy my need to know who he was. As the years passed, I tracked back to the library and to Marquis to learn who other authors were whose books were influencing me. I did this, for example, in 1977 after reading my first book by Professor Linus Pauling, Vitamin C and the Common Cold. A year ago, I received an invitation from Marquis Who's Who in America to submit biographical information to their review committee. Last week, I received notice that from 2008, starting with its 62nd edition, I'll be included in Marquis. The Marquis committee notes, "Since 1899, Who's Who in America has chronicled the lives and careers of America's most noteworthy men and women . . . Marquis Who's Who believes the men and women around the globe whose achievements influence the people of today are worthy of permanent record, and we are proud to provide their biographical information for public record and for posterity." I am happy that I'm still around to learn of my inclusion
in Marquis, along with people whom I immensely respect, such as Dr.
Ellis and Prof. Pauling. And I profoundly appreciate this most respected biographical
source for recording my main contributions and making them available to
those who use Marquis.
Our Menu of Services: We have a menu of my husband's clinical services and fees. We put the menu together so that you can avail yourself of some or all of the services, whichever best fits your budget. If you want to talk about Dr. Lowe's services, you can reach our clinical assistant, Maureen Donahoe, or me by phone at 603-391-6061. If you prefer, you can email me at Tammy@drlowe.comm. However, we also have a webpage where we describe our menu of services: Your Options for Metabolic Evaluations and Treatment. The Lowe Clinic and Research Center © 2007 John C. Lowe. All rights reserved. This email newsletter may be copied and distributed subject to three conditions: (1) All text within the full document or any section copied must be copied without modification with all pages included. (2) All copies must contain the following copyright notice: "© 2007 John C. Lowe." (3) Neither this full document nor any section of it may be published or distributed for profit. |